Search results for "fusion"

showing 10 items of 4513 documents

High Quality Reconstruction of Dynamic Objects using 2D-3D Camera Fusion

2017

International audience; In this paper, we propose a complete pipeline for high quality reconstruction of dynamic objects using 2D-3D camera setup attached to a moving vehicle. Starting from the segmented motion trajectories of individual objects, we compute their precise motion parameters, register multiple sparse point clouds to increase the density, and develop a smooth and textured surface from the dense (but scattered) point cloud. The success of our method relies on the proposed optimization framework for accurate motion estimation between two sparse point clouds. Our formulation for fusing it closest-point and it consensus based motion estimations, respectively in the absence and pres…

2D-3D FusionPoint cloudComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION02 engineering and technologyIterative reconstructionRANSAC[ INFO.INFO-CV ] Computer Science [cs]/Computer Vision and Pattern Recognition [cs.CV]Vehicle dynamics[INFO.INFO-CV] Computer Science [cs]/Computer Vision and Pattern Recognition [cs.CV]Robustness (computer science)Motion estimationPoint Cloud Registration0502 economics and business[ INFO.INFO-TI ] Computer Science [cs]/Image Processing0202 electrical engineering electronic engineering information engineeringComputer visionComputingMethodologies_COMPUTERGRAPHICS050210 logistics & transportationRANSACbusiness.industry05 social sciences3D reconstruction[INFO.INFO-CV]Computer Science [cs]/Computer Vision and Pattern Recognition [cs.CV]020207 software engineeringICPGeography[INFO.INFO-TI] Computer Science [cs]/Image Processing [eess.IV][INFO.INFO-TI]Computer Science [cs]/Image Processing [eess.IV]Artificial intelligencebusiness3D ReconstructionSurface reconstruction
researchProduct

"Table 12: Cross-section limits lepton specific tanb 1" of "Search for a heavy Higgs boson decaying into a $Z$ boson and another heavy Higgs boson in…

2018

The cross section times BR(A->ZH) times BR(H->bb) limits for an A boson in the lepton specific, tanbeta 1, 2HDM. For each signal point, characterised by the mass pair (mA, mH), two limits are provided, the observed and the expected. The correct width as predicted by this particular parameter choice of the 2HDM is used. For lepton specific only gluon-gluon fusion is used and the nb=2 category only.

2HDMHIGGS --> BQ BQBAR13000.0CLSHigh Energy Physics::Phenomenologycross section limitsZ0 --> MU+ MU-Z0 --> E+ E-P P --> HIGGSgluon-gluon fusionHigh Energy Physics::ExperimentHiggs boson productionHIGGS --> Z0 HIGGSgluon fusion
researchProduct

"Table 14: Cross-section limits lepton specific tanb 3" of "Search for a heavy Higgs boson decaying into a $Z$ boson and another heavy Higgs boson in…

2018

The cross section times BR(A->ZH) times BR(H->bb) limits for an A boson in the lepton specific, tanbeta 3, 2HDM. For each signal point, characterised by the mass pair (mA, mH), two limits are provided, the observed and the expected. The correct width as predicted by this particular parameter choice of the 2HDM is used. For lepton specific only gluon-gluon fusion is used and the nb=2 category only.

2HDMHIGGS --> BQ BQBAR13000.0CLSHigh Energy Physics::Phenomenologycross section limitsZ0 --> MU+ MU-Z0 --> E+ E-P P --> HIGGSgluon-gluon fusionHigh Energy Physics::ExperimentHiggs boson productionHIGGS --> Z0 HIGGSgluon fusion
researchProduct

"Table 13: Cross-section limits lepton specific tanb 2" of "Search for a heavy Higgs boson decaying into a $Z$ boson and another heavy Higgs boson in…

2018

The cross section times BR(A->ZH) times BR(H->bb) limits for an A boson in the lepton specific, tanbeta 2, 2HDM. For each signal point, characterised by the mass pair (mA, mH), two limits are provided, the observed and the expected. The correct width as predicted by this particular parameter choice of the 2HDM is used. For lepton specific only gluon-gluon fusion is used and the nb=2 category only.

2HDMHIGGS --> BQ BQBAR13000.0CLSHigh Energy Physics::Phenomenologycross section limitsZ0 --> MU+ MU-Z0 --> E+ E-P P --> HIGGSgluon-gluon fusionHigh Energy Physics::ExperimentHiggs boson productionHIGGS --> Z0 HIGGSgluon fusion
researchProduct

Stabilization of unilamellar catanionic vesicles induced by β-cyclodextrins: A strategy for a tunable drug delivery depot.

2018

The limited stability of catanionic vesicles has discouraged their wide use for encapsulation and controlled release of active substances. Their structure can easily break down to form lamellar phases, micelles or rearrange into multilamellar vesicles, as a consequence of small changes in their composition. However, despite the limited stability, catanionic vesicles possess an attractive architecture, which is able to efficiently encapsulate both hydrophobic and hydrophilic molecules. Therefore, improving the stability of the vesicles, as well as the control on unilamellar structures, are prerequisites for their wider application range. This study focuses on the impact of β-cyclodextrins fo…

3003DepotPharmaceutical Science02 engineering and technology010402 general chemistry01 natural sciencesMicelleDiffusionSurface-Active AgentsDrug Delivery SystemsCyclodextrinLamellar structureUnilamellar Liposomeschemistry.chemical_classificationCatanionic vesiclesCyclodextrinChemistryCetrimoniumVesiclebeta-Cyclodextrinstechnology industry and agricultureTemperatureSodium Dodecyl SulfateCatanionic vesicles; Cyclodextrin; Diffusion; NMR; Self-assembly; 3003Self-assembly021001 nanoscience & nanotechnologyCatanionic vesicleControlled releaseNMR0104 chemical sciencesChemical engineeringSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryCetrimonium Compoundslipids (amino acids peptides and proteins)Self-assembly0210 nano-technologyInternational journal of pharmaceutics
researchProduct

Buccal drug delivery: what's new and what does the future hold?

2014

The buccal mucosa is the stratified squamous epithelial tissue inside lining of the cheeks. It is a favorable site of drug absorption since the tissue is non-keratinized, relatively immobile and strongly supplied with blood by a dense capillary-vessel network; moreover, it is highly tolerant to allergens, resistant to potentially harmful agents and has a relatively low enzymatic activity. The tissue consents quick onset of effect, offers an easily accessible and generally well-accepted site for drug delivery, is a useful route of administration in patients in an unconscious state (e.g., when swallowing is impaired), and is suitable for retentive dosage forms of administration. Buccal mucosa…

3003Drugmedia_common.quotation_subjectChemistry PharmaceuticalPharmaceutical ScienceDentistryPharmacologyDosage formRoute of administrationDrug Delivery SystemsPharmacokineticsMucositisMedicineAnimalsHumansBuccal dosage formmedia_commonDosage FormsDrug Carriersbusiness.industryLocoregional/systemic treatmentMedicine (all)Mouth MucosaAdministration BuccalTransmucosal deliveryBuccal administrationmedicine.diseaseBioavailabilityPharmaceutical PreparationsSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryBuccal mucosaDiffusion of InnovationbusinessForecastingTherapeutic delivery
researchProduct

Development of a novel in vitro system for biomedical applications

2022

Nella ricerca scientifica e medica, l'uso degli animali ha apportato notevoli benefici all’uomo. Sebbene la loro fisiologia non imiti perfettamente il corpo umano, essi agiscono come perfetti "modelli" per lo studio delle malattie umane e lo sviluppo di nuovi farmaci e trattamenti. Tuttavia, secondo la Food and Drug Administration (FDA), solo l'8% dei farmaci testati sugli animali è considerato sicuro ed efficace per l'uso sull’essere umano, il 92% non lo è. Questi tassi di fallimento estremamente elevati nello sviluppo di farmaci, insieme ai costi in forte aumento, hanno portato molti ricercatori a rivalutare il valore degli studi in vivo sugli animali. Questo è stato il motivo per cui, ne…

3D in vitro cell culturePLLA scaffolddual-flow perfusion bioreactorSettore ING-IND/34 - Bioingegneria Industrialenanoparticles
researchProduct

Genomic organization and promoter characterization of the gene encoding a putative endoplasmic reticulum chaperone, ERp29

2002

Abstract ERp29 is a soluble protein localized in the endoplasmic reticulum (ER) of eukaryotic cells, which is conserved in all mammalian species. The N-terminal domain of ERp29 displays sequence and structural similarity to the protein disulfide isomerase despite the lack of the characteristic double cysteine motif. Although the exact function of ERp29 is not yet known, it was hypothesized that it may facilitate folding and/or export of secretory proteins in/from the ER. ERp29 is induced by ER stress, i.e. accumulation of unfolded proteins in the ER. To gain an insight into the mechanisms regulating ERp29 expression we have cloned and characterized the rat ERp29 gene and studied in details …

5' Flanking RegionRecombinant Fusion ProteinsMolecular Sequence DataCHO CellsBiologyCell LineMiceCricetinaeSequence Homology Nucleic AcidGene expressionTumor Cells CulturedGeneticsAnimalsHumansRNA MessengerLuciferasesPromoter Regions GeneticProtein disulfide-isomeraseGeneHeat-Shock ProteinsPhylogenyBase SequenceGene Expression ProfilingEndoplasmic reticulumPromoter3T3 CellsDNAExonsSequence Analysis DNAGeneral MedicineMolecular biologyIntronsRatsHousekeeping geneSecretory proteinGenesUnfolded protein responseFemaleTranscription Initiation SiteSequence AlignmentHeLa CellsGene
researchProduct

Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice

2019

Alessio Cortellini,1,2 Katia Cannita,1 Alessandro Parisi,1,2 Paola Lanfiuti Baldi,1 Olga Venditti,1 Carla D’Orazio,1,2 Antonella Dal Mas,3 Giuseppe Calvisi,3 Aldo V Giordano,4 Vincenzo Vicentini,5 Roberto Vicentini,5 Lara Felicioni,6 Antonio Marchetti,7 Fiamma Buttitta,6 Antonio Russo,8 Corrado Ficorella1,2 1Medical Oncology, St Salvatore Hospital, University of L’Aquila, L’Aquila, Italy; 2Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy; 3Department of Pathology, St Salvatore Hospital L’Aquila, L’Aquila, Italy; 4Diagnostic and Interventional Radiology, St Salvatore Hos…

5-fluorouracil infusion; Bevacizumab; Clinical practice; Intensive chemotherapy regimen; Metastatic colorectal cancerintensive chemotherapy regimenmetastatic colorectal cancer intensive chemotherapy regimen bevacizumab clinical practice 5-fluorouracil infusionmetastatic colorectal cancer5-fluorouracil infusionbevacizumabOncoTargets and TherapyOriginal Researchclinical practiceOncoTargets and therapy
researchProduct

Surface charges at the CaF2/water interface allow very fast intermolecular vibrational-energy transfer

2020

Abstract We investigate the dynamics of water in contact with solid calcium fluoride, where at low pH, localized charges can develop upon fluorite dissolution. We use 2D surface‐specific vibrational spectroscopy to quantify the heterogeneity of the interfacial water (D2O) molecules and provide information about the sub‐picosecond vibrational‐energy‐relaxation dynamics at the buried solid/liquid interface. We find that strongly H‐bonded OD groups, with a vibrational frequency below 2500 cm−1, display very rapid spectral diffusion and vibrational relaxation; for weakly H‐bonded OD groups, above 2500 cm−1, the dynamics slows down substantially. Atomistic simulations based on electronic‐structu…

540 Chemistry and allied sciencesMaterials science530 Physics2D sum-frequency generation010402 general chemistry01 natural sciencesCatalysisVibrational energy relaxationSurface chargeDiffusion (business)DissolutionResearch Articlesenergy transfer010405 organic chemistryIntermolecular forceGeneral ChemistryInterfacial Chemistryab-initio molecular dynamics530 Physik0104 chemical sciencesDipoleSolvation shellChemical physicsMolecular vibration540 Chemiesolid/liquid interfacesResearch Article
researchProduct